R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

At Reuters Pharma Europe, Sandoz' Claire D'Abreu-Hayling explored the promise of the so-called “golden decade” of patent expiry for generics.

R&D

Longevity has been discussed for a while now in the context of life sciences and pharma - we take a look at what's new now with Anat Naschitz.

R&D

In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Boyang Wang, the founder of Immortal Dragons.

R&D

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

R&D

Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.

R&D

For CROs and CDMOs, automation is key to ensuring long-term success.